Non-Hodgkin's lymphomas (NHLs) are a much more heterogeneous group of malignant tumours than Hodgkin’s lymphomas. A working formulation divides the NHLs into low-, intermediate-, and high-grade
groups. Low-grade lymphomas are usually follicular; while the intermediate- and high-grade tumours are usually diffuse. To eliminate the confusion created by multiple classification schemes, three
primary subtypes of high-grade NHL have been defined: small noncleaved cell (SNCC), lymphoblastic, and large cell. The SNCC NHLs (Burkitt and non-Burkitt subtypes) are B-cell tumours that express
surface immunoglobulin and contain one of three characteristic chromosomal translocations. Burkitt’s and Burkitt-like non-Hodgkin's lymphoma are rare entities, which account for nearly 50% of
all NHLs in children, but only 2%–3% in immunocompetent adults. The NHLs of childhood, in contrast with those of adults, are usually diffuse, extranodal, high-grade tumours. Their incidence has
increased since the 1980s, mainly due to the increased risk of NHL associated with infection with the human immunodeficiency virus. These diseases are aggressive, potentially curable, B-cell
neoplasms. The classical and endemic forms of Burkitt’s lymphoma were first described in African children and are the commonest childhood malignancies in some parts of Africa. They are
classified as a ‘diffuse’ tumour at presentation and do not readily conform to conventional staging systems, the prognosis being related to tumour volume rather than site. The rarer,
non-endemic Burkitt’s and Burkitt-like forms, subsequently described in North American series, are aggressive diseases that affect an older age group, and presentation is usually with
extranodal abdominal masses, characteristically involving the distal ileum or caecum, and peripheral lymphadenopathy. Burkitt-like non-Hodgkin's lymphoma is a less well-defined, but clinically
similar disease to the Burkitt’s lymphoma and has been classified as a provisional entity in the REAL classification. The presenting signs and symptoms of Burkitt’s and Burkitt-like NHLs
are largely determined by the site of the disease and its extent. The most frequent primary sites are the abdomen (31.4%), mediastinum (26%), and the head/neck region, including Waldeyer ring and/or
cervical lymph nodes (8%–25%). The incidence reported in other series of nonendemic Burkitt’s varies from 0% to 33%. A central nervous system disease may result in headache, increased
intracranial pressure, or cranial nerve palsies. Isolated Cavernous Sinus Syndrome is not a common presentation of secondary lymphoma of the central nervous system. Meningeal and cranial nerve
infiltration are the most common CNS findings in Burkitt’s and Burkitt-like lymphoma, which are difficult to demonstrate on CT. An MRI is expected to be more sensitive in revealing the
infiltration. A CT appears to be the most effective method of accurately staging the patients. In our case, the rapid growth of the patient’s symptoms suggested a malignant nature. There are no
radiological features specific to this condition, but the presence of extranodal disease involving the bowe,l particularly in the ileocaecal region, together with an aggressive clinical history, in a
young patient, should suggest the possibility of this diagnosis. An urgent imaging is required to access the initial tumour bulk, the compromise of vital organs and for the follow-up of patients
during therapy.